BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vécsei E, Steinwendner S, Kogler H, Innerhofer A, Hammer K, Haas OA, Amann G, Chott A, Vogelsang H, Schoenlechner R, Huf W, Vécsei A. Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study. BMC Gastroenterol 2014;14:28. [PMID: 24524430 DOI: 10.1186/1471-230X-14-28] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Buoli Comani G, Panceri R, Dinelli M, Biondi A, Mancuso C, Meneveri R, Barisani D. miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation. Genes Nutr 2015;10:482. [PMID: 26233308 DOI: 10.1007/s12263-015-0482-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
2 Leonard MM, Cureton P, Fasano A. Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease. Nutrients. 2017;9. [PMID: 29057833 DOI: 10.3390/nu9101129] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
3 Ludvigsson JF, Agreus L, Ciacci C, Crowe SE, Geller MG, Green PH, Hill I, Hungin AP, Koletzko S, Koltai T, Lundin KE, Mearin ML, Murray JA, Reilly N, Walker MM, Sanders DS, Shamir R, Troncone R, Husby S. Transition from childhood to adulthood in coeliac disease: the Prague consensus report. Gut 2016;65:1242-51. [PMID: 27196596 DOI: 10.1136/gutjnl-2016-311574] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
4 Leonard MM, Karathia H, Pujolassos M, Troisi J, Valitutti F, Subramanian P, Camhi S, Kenyon V, Colucci A, Serena G, Cucchiara S, Montuori M, Malamisura B, Francavilla R, Elli L, Fanelli B, Colwell R, Hasan N, Zomorrodi AR, Fasano A;  CD-GEMM Team. Multi-omics analysis reveals the influence of genetic and environmental risk factors on developing gut microbiota in infants at risk of celiac disease. Microbiome. 2020;8:130. [PMID: 32917289 DOI: 10.1186/s40168-020-00906-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
5 Szakács Z, Mátrai P, Hegyi P, Szabó I, Vincze Á, Balaskó M, Mosdósi B, Sarlós P, Simon M, Márta K, Mikó A, Pécsi D, Demcsák A, Bajor J. Younger age at diagnosis predisposes to mucosal recovery in celiac disease on a gluten-free diet: A meta-analysis. PLoS One 2017;12:e0187526. [PMID: 29095937 DOI: 10.1371/journal.pone.0187526] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
6 Silvester JA, Kurada S, Szwajcer A, Kelly CP, Leffler DA, Duerksen DR. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis. Gastroenterology 2017; 153: 689-701. e1. [PMID: 28545781 DOI: 10.1053/j.gastro.2017.05.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 13.8] [Reference Citation Analysis]
7 Husby S, Murray JA, Katzka DA. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review. Gastroenterology. 2019;156:885-889. [PMID: 30578783 DOI: 10.1053/j.gastro.2018.12.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
8 Packova B, Kovalcikova P, Pavlovsky Z, Bartusek D, Prokesova J, Dolina J, Kroupa R. Non-invasive prediction of persistent villous atrophy in celiac disease. World J Gastroenterol 2020; 26(26): 3780-3791 [PMID: 32774057 DOI: 10.3748/wjg.v26.i26.3780] [Reference Citation Analysis]
9 Comino I, Segura V, Ortigosa L, Espín B, Castillejo G, Garrote JA, Sierra C, Millán A, Ribes-Koninckx C, Román E, Rodríguez-Herrera A, Díaz J, Silvester JA, Cebolla Á, Sousa C. Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet. Aliment Pharmacol Ther 2019;49:1484-92. [PMID: 31074004 DOI: 10.1111/apt.15277] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
10 Leonard MM, Weir DC, DeGroote M, Mitchell PD, Singh P, Silvester JA, Leichtner AM, Fasano A. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet. J Pediatr Gastroenterol Nutr. 2017;64:286-291. [PMID: 28112686 DOI: 10.1097/mpg.0000000000001460] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 8.8] [Reference Citation Analysis]